Mira Pharmaceuticals (MIRA) P/E (2023 - 2026)
Mira Pharmaceuticals (MIRA) P/E from Aug 3, 2023 to Jul 21, 2026. The TTM Mira Pharmaceuticals (MIRA) P/E is -3.19. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Mira Pharmaceuticals (MIRA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -3.19 | -22.71% |
| 2025 | -4.13 | +116.84% |
| 2024 | -1.90 | -2.06% |
| 2023 | -1.94 | N/A |
Comparison Mira Pharmaceuticals (MIRA) P/E with competitors
Mira Pharmaceuticals (MIRA) P/E is -3.19.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| GRFS | Grifols SA | 10.11 | -416.94% |
| PFE | Pfizer Inc | 11.65 | -465.36% |
| NVO | Novo Nordisk | 11.79 | -469.67% |
| GSK | GSK Plc | 12.10 | -479.47% |
| SNY | Sanofi | 12.12 | -480.11% |
| BMY | Bristol-Myers Squibb Company | 13.82 | -533.25% |
| OGN | Organon & Company | 14.33 | -549.16% |
| BIIB | Biogen Inc | 17.41 | -645.68% |
| GILD | Gilead Sciences Inc | 17.75 | -656.32% |
| NVS | Novartis AG | 21.60 | -777.08% |
| JNJ | Johnson & Johnson | 22.09 | -792.48% |
| AMGN | AMGEN Inc | 24.75 | -875.97% |
| MRK | Merck & Co Inc | 26.93 | -944.18% |
| AZN | Astrazeneca plc | 28.44 | -991.71% |
| LLY | Lilly(Eli) & Company | 48.44 | -1618.73% |
| ABBV | Abbvie Inc | 139.08 | -4460.31% |